Congratulations to Cota CEO, Miruna Sasu who has been named one of the Top 25 CEOs in Biotech 2022 by The Healthcare Technology Report. Miruna is joined on a list of exceptional women in healthcare who are working to improve science and health through innovation.
Read Full Release
COTA, Inc. , an oncology real-world data and analytics company, announced a new partnership with Google Cloud to develop algorithms that will extract and make sense of unstructured data from electronic health records (EHRs). The companies will apply machine learning and natural language processing to curate text fields like clinician notes, transforming them into structured fields that can be used for research and analytics.
Read Full Release
BMP portfolio company, SomaLogic, (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced findings from key studies demonstrating the broad and deep role proteomics plays in detecting cardiovascular risk, achieving optimal cardiometabolic health, and assessing the correlation of cardiovascular disease with other diseases that are among the leading causes of death around the world. SomaLogic and its research partners will present these studies at American Heart Association Scientific Sessions in Chicago on November 5-7, 2022.
Read Full Release
Dana Callow will be speaking at the @DTRA Annual Meeting in Boston November 8th as part of an Investor Panel discussing PE, late-stage VC, early-stage VC, and Strategic Investments. This conversation will be very timely given our current economic environment, and our ecosystem including a range of companies from early through IPO. Join us as we gather leading visionaries in decentralized research and clinical trials to share ideas, develop lasting connections, and create new bonds over our shared mission to make patient-focused research accessible to everyone. #decentralizedclinicaltrials #DTRA2022
Read Full Release
SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that management will be participating in the upcoming Capital One Spatial Biology & Proteomics Summit taking place virtually on Wednesday, September 28.
Roy Smythe, M.D, SomaLogic’s Chief Executive Officer is scheduled to participate in two panel discussions.
Proteomics “Everything You Wanted to Know, But Were Afraid to Ask”
Executive Panel Discussion at 10:15 a.m. Eastern Time
CEOs from Spatial Biology/Proteomics
Executive Panel Discussion at 1:00 p.m. Eastern Time
Read Full Release
Boston Millennia is pleased to announce the sale of our portfolio company, Forefront Telehealth, Inc. to Access TeleCare, a company focused on behavioral health, in a cash and stock transaction.
Forefront is a leading provider of virtual behavioral health solutions across the care continuum for seniors and other vulnerable adults. For over ten years, Forefront has provided the highest quality telepsychiatry and teletherapy care for patients in hospitals, long-term care, and home health settings.
Access TeleCare, (prior to this transaction known as SOC Telehealth) is the country’s largest provider of acute and specialty telemedicine, Access TeleCare works with hospitals, outpatient clinics, long-term care facilities, home health companies, and physician practices to provide telemedicine services in neurology, behavioral health, hospitalist medicine, pulmonary and critical care, maternal-fetal medicine, infectious disease, cardiology, nephrology, and endocrinology. BMP IV will maintain a position in the merged company, as their roll-up approach is consistent with BMP’s Core Company, “buy and build” strategy which we have implemented successfully for many years.
Read Full Release
KAID Health, an AI-powered health care data analysis and provider engagement platform, announced the results of a study that validates the potential utility of its Natural Language Processing (NLP) technology to improve provider efficiency and care quality. The peer-reviewed “doctor vs. artificial intelligence” paper found that KAID Health’s NLP technology greatly aligned with the clinician reviewers in completing a pre-operative checklist, and further was able to identify 16.6% of instances where the presence or absence of a specific condition was not found by the anesthesiologist. The research study was undertaken at UCSD’s Department of Anesthesiology, Division of Perioperative Informatics.
Read Full Release
Walgreens announced today their new clinical trial business will partner with BMP portfolio company Pluto Health. Pluto Health's multi-layered, smart care coordination service that unifies siloed health information from multiple places (such as medical records, social determinants of health, insurance claims and more) within 30 minutes will enhance the patient experience. The Pluto Health team evaluates patient health information with the recommended clinical care guidelines and social determinants of health data to identify and close any potential gaps in care. This helps ensure every patient receives the best possible care through up-to-date screenings, vaccinations and other health interventions, such as clinical research as a care option.
Read Full Release
BMP Managing General Partner, Dana Callow and Partner Jessica Federer will both chair panels at this year's DIA Global Annual Meeting in Chicago. Dana will host a forum "Accelerating Innovation Through Investing". This forum delves into the state of strategic investments from both pharmaceutical venture teams and institutional investors, exploring best practices to collectively advance research and care. Jessica will host a forum " Where Are we Really on Data Interoperability?". This session explores the current status of interoperability and data collaborations while giving insights into the challenges we currently face, and the value still left to be realized. We hope if you will be at DIA you will join us for two interesting discussions.
Read Full Release
SomaLogic, a leader in data-driven proteomics technology, today announced it has signed a licensing agreement with OncoHost, a global leader in next-generation precision oncology for personalized cancer therapy. As part of the agreement, OncoHost will license SomaLogic’s SomaScan® Platform to develop proteomics tests for its PROphet® diagnostic system, designed to predict patient response to immunotherapy treatments and provide strategies to overcome treatment resistance. The collaboration reflects SomaLogic’s commitment to leveraging its industry leading assay capabilities in the development of high-plex proteomic diagnostic tests.
Read Full Release
